Hester Biosciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 672.99 million compared to INR 564.69 million a year ago. Revenue was INR 704.87 million compared to INR 636.61 million a year ago. Net income was INR 45.31 million compared to INR 77.23 million a year ago. Basic earnings per share from continuing operations was INR 6.72 compared to INR 10.59 a year ago.
For the full year, sales was INR 2,660.91 million compared to INR 2,350.06 million a year ago. Revenue was INR 2,812.42 million compared to INR 2,487.47 million a year ago. Net income was INR 266.27 million compared to INR 393.2 million a year ago. Basic earnings per share from continuing operations was INR 32.96 compared to INR 46.41 a year ago.